CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 145 enrolled
Drug / intervention
Carbowhite +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03633344
NCT03633344Phase 2Completed
CompareCT.gov

Efficacy of the Administration of Colloidal Silicon Dioxide in Tablet Dosage Form (Carbowhite) in Patients With Acute Diarrhea.

Omnifarma Kiev LLC·interventional·Posted Aug 16, 2018·Updated Jun 6, 2019

In Brief

A Phase 2 clinical trial evaluating Carbowhite and Carbowhite placebo for Diarrhoea;Acute. Completed, enrolled 145 participants.

Detailed Summary

The purpose of the study is to demonstrate the antidiarrheal efficacy of colloidal silicon dioxide in tablet dosage form (Carbowhite) in patients with acute diarrhea.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiarrhoea;Acute
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 16, 2018
Enrollment StartMar 29, 2016
Primary CompletionOct 7, 2016
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.9 years ago

Interventions

Carbowhitedrug

Carbowhite placebodrug